To our knowledge, immune modulation in the areas of metastasis is poorly understood; a dynamic model should be employed to better follow how T cell-mediated anti-tumor immune responses are regulated in the presence of SCLC cells, i.e. potentially CSC-like CD44+ fraction. This evidence concerns the gene CD44 and neoplasm.